Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach

1. Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P et al. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement from an International Expert Panel. Diabetes. 2020;69(10):2037-2047.10.2337/dbi20-0017780971732847960 Search in Google Scholar

2. Hernández M, Mauricio D. Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues. Advances in Experimental Medicine and Biology; 2020. p. 29-41.10.1007/5584_2020_53332424495 Search in Google Scholar

3. Pieralice S, Pozzilli P. Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management. Diabetes Metab J. 2018;42(6):451-464.10.4093/dmj.2018.0190630044030565440 Search in Google Scholar

4. Classification of diabetes mellitus. Geneva: World Health Organization; 2019. Search in Google Scholar

5. Nishimura A, Matsumura K, Kikuno S, et al. Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives. Diabetes Metab Syndr Obes. 2019;12:2461-2477.10.2147/DMSO.S191007688659231819572 Search in Google Scholar

6. Naik R, Brooks-Worrell B, Palmer J. Latent Autoimmune Diabetes in Adults. The Journal of Clinical Endocrinology & Metabolism. 2009;94(12):4635-4644.10.1210/jc.2009-112019837918 Search in Google Scholar

7. Zinman B, Kahn S, Haffner S, O’Neill M, Heise M, Freed M. Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe. Diabetes. 2004;53(12):3193-3200.10.2337/diabetes.53.12.319315561950 Search in Google Scholar

8. Andersen M. New Insights into the Genetics of Latent Autoimmune Diabetes in Adults. Current Diabetes Reports. 2020;20(9).10.1007/s11892-020-01330-y32725517 Search in Google Scholar

9. Jörns A, Wedekind D, Jähne J, Lenzen S. Pancreas pathology of latent autoimmune diabetes in adults (LADA) in patients and in a LADA rat model compared with type 1 diabetes. Diabetes. 2020;69:624–633.10.2337/db19-086531974139 Search in Google Scholar

10. Buzzetti R, Zampetti S, Maddaloni E. Adult-onset autoimmune diabetes: current knowledge and implications for management. Nature Reviews Endocrinology. 2017;13(11):674-686.10.1038/nrendo.2017.9928885622 Search in Google Scholar

11. Chen W, Chen X, Zhang M, Huang Z. The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data. Gene. 2021;767:145177.10.1016/j.gene.2020.14517732998048 Search in Google Scholar

12. Laugesen E, Østergaard JA, Leslie RD; Danish Diabetes Academy Workshop and Workshop Speakers. Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015 Jul;32(7):843-852.10.1111/dme.12700467629525601320 Search in Google Scholar

13. Desai M, Zeggini E, Horton V, Owen K, Hattersley A, Levy J et al. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia. 2006;50(1):68-73.10.1007/s00125-006-0513-z307620717143607 Search in Google Scholar

14. Maddaloni E, Moretti C, Mignogna C, Buzzetti R. Adult-onset autoimmune diabetes in 2020: An update. Maturitas. 2020 Jul;137:37-44.10.1016/j.maturitas.2020.04.01432498935 Search in Google Scholar

15. Hawa M, Kolb H, Schloot N, Beyan H, Paschou S, Buzzetti R et al. Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care. 2012;36(4):908-913.10.2337/dc12-0931360950423248199 Search in Google Scholar

16. Lampasona V, Pittman DL, Williams AJ, et al. Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance. Clin Chem. 2019;65(9):1141-1152.10.1373/clinchem.2019.304196893613531409598 Search in Google Scholar

17. Zhu Y, Qian L, Liu Q, et al. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function. Diabetes Metab J. 2020;44(2):260-266.10.4093/dmj.2019.0007718896831769235 Search in Google Scholar

18. Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo G, Buzzetti R et al. Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2. Diabetes. 2008;57(5):1276-1283.10.2337/db07-087418332100 Search in Google Scholar

19. Li XH, Yu FF, Zhou YH, He J. Association between alcohol consumption and the risk of incident type 2 diabetes: A systematic review and dose-response meta-analysis. Am J Clin Nutr. 2016;103(3):818-829.10.3945/ajcn.115.11438926843157 Search in Google Scholar

20. Carlsson S. Environmental (Lifestyle) Risk Factors for LADA. Current Diabetes Reviews. 2019;15(3):178-187.10.2174/157339981466618071615025330009710 Search in Google Scholar

21. Hjort R, Ahlqvist E, Carlsson PO, et al. Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study. Diabetologia. 2018;61(6):1333-1343.10.1007/s00125-018-4596-0644899829589073 Search in Google Scholar

22. Löfvenborg JE, Ahlqvist E, Alfredsson L, Andersson T, Groop L, Tuomi T, Wolk A, Carlsson S. Consumption of red meat, genetic susceptibility, and risk of LADA and type 2 diabetes. Eur J Nutr. 2021 Mar;60(2):769-779.10.1007/s00394-020-02285-2790003632444887 Search in Google Scholar

23. Hjort R, Alfredsson L, Andersson T, et al. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). Diabetes Metab. 2017;43(6):536-542.10.1016/j.diabet.2017.05.01028669512 Search in Google Scholar

24. Banerjee P, Khan NZ, Singh ST, Singh N, Qamar I. Latent autoimmune diabetes in adults: complication, management and treatment modalities. Endocrinol Metab Int J.2019;7(3):67-72.10.15406/emij.2019.07.00246 Search in Google Scholar

25. Zaharia OP, Bobrov P, Strassburger K, et al. Metabolic Characteristics of Recently Diagnosed Adult-Onset Autoimmune Diabetes Mellitus. J Clin Endocrinol Metab. 2018;103(2):429-437.10.1210/jc.2017-0170629220505 Search in Google Scholar

26. Rajkumar V, Levine SN. Latent Autoimmune Diabetes. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 18; 2021. Search in Google Scholar

27. Fadiga L, Saraiva J, Catarino D, Frade J, Melo M, Paiva I. Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation. Diabetol Metab Syndr. 2020;12(1):107.10.1186/s13098-020-00616-1771331533292447 Search in Google Scholar

28. Mishra R, Hodge KM, Cousminer DL, Leslie RD, Grant SFA. A Global Perspective of Latent Autoimmune Diabetes in Adults. Trends Endocrinol Metab. 2018;29(9):638-650.10.1016/j.tem.2018.07.00130041834 Search in Google Scholar

29. Castelblanco E, Hernández M, Castelblanco A, et al. Low-grade Inflammatory Marker Profile May Help to Differentiate Patients With LADA, Classic Adult-Onset Type 1 Diabetes, and Type 2 Diabetes. Diabetes Care. 2018;41(4):862-868.10.2337/dc17-166229358494 Search in Google Scholar

30. Koufakis T, Katsiki N, Zebekakis P, Dimitriadis G, Kotsa K. Therapeutic approaches for latent autoimmune diabetes in adults: One size does not fit all. J Diabetes. 2020;12(2):110-118.10.1111/1753-0407.1298231449359 Search in Google Scholar

31. Gribble FM, Ashcroft FM. Differential sensitivity of beta-cell and extrapancreatic KATP channels to gliclazide. Diabetologia. 1999;42:845-848.10.1007/s00125005123610440127 Search in Google Scholar

32. Engler RL, Yellon DM. Sulfonylurea KATP Blockade in Type II Diabetes and Preconditioning in Cardiovascular Disease. Circulation. 1996;94:2297-2301.10.1161/01.CIR.94.9.2297 Search in Google Scholar

33. Heller SR; ADVANCE Collaborative Group. A summary of the ADVANCE Trial. Diabetes Care. 2009;32 Suppl 2(Suppl 2):S357-S361.10.2337/dc09-S339281145119875581 Search in Google Scholar

34. Avogaro A. Treating diabetes today with gliclazide MR: a matter of numbers. Diabetes Obes Metab. 2012 Jan;14 Suppl 1:14-19.10.1111/j.1463-1326.2011.01508.x22118706 Search in Google Scholar

35. Zhang Z, Yan X, Wu C, et al. Adding vitamin D3 to the dipeptidyl peptidase-4 inhibitor saxagliptin has the potential to protect β-cell function in LADA patients: A 1-year pilot study. Diabetes Metab Res Rev. 2020;36(5):e3298.10.1002/dmrr.329832043288 Search in Google Scholar

36. Pinheiro MM, Pinheiro FMM, Diniz SN, Fabbri A, Infante M. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes. Int Immunopharmacol. 2021;95:107518.10.1016/j.intimp.2021.10751833756226 Search in Google Scholar

37. Latif A, Gastelum AA, Sood A, Reddy JT. Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin). BMJ Case Rep. 2020;13(6):e235117.10.1136/bcr-2020-235117728229332513767 Search in Google Scholar

38. White-Cotsmire AJ, Healy AM. Ketogenic Diet as a Trigger for Diabetic Ketoacidosis in a Misdiagnosis of Diabetes: A Case Report. Clin Diabetes. 2020;38(3):318-321.10.2337/cd20-0001736445832699486 Search in Google Scholar

39. Pozzilli P, Leslie RD, Peters AL, et al. Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials. Diabetes Obes Metab. 2018;20(6):1490-1498.10.1111/dom.1323729377522 Search in Google Scholar

40. Liu B, Xiang Y, Liu Z, Zhou Z. Past, present and future of latent autoimmune diabetes in adults. Diabetes Metab Res Rev. 2020;36(1):e3205.10.1002/dmrr.320531318117 Search in Google Scholar

41. Wod M, Thomsen RW, Pedersen L, Yderstraede KB, Beck-Nielsen H, Højlund K. Lower mortality and cardiovascular event rates in patients with Latent Autoimmune Diabetes In Adults (LADA) as compared with type 2 diabetes and insulin deficient diabetes: A cohort study of 4368 patients. Diabetes Res Clin Pract. 2018;139:107-113.10.1016/j.diabres.2018.02.04229518492 Search in Google Scholar

42. Issar T, Yan A, Kwai NCG, et al. Altered peripheral nerve structure and function in latent autoimmune diabetes in adults. Diabetes Metab Res Rev. 2020;36(3):e3260.10.1002/dmrr.326031833206 Search in Google Scholar

43. Alam U, Jeziorska M, Petropoulos IN, et al. Latent autoimmune diabetes of adulthood (LADA) is associated with small fibre neuropathy. Diabet Med. 2019;36(9):1118-1124.10.1111/dme.1388830575096 Search in Google Scholar

44. Carlsson S. Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes. Front Physiol. 2019;10:320.10.3389/fphys.2019.00320644405930971952 Search in Google Scholar

45. Frazier AR. Correct Diabetes Diagnosis and Treatment Allows Sailor to Remain on Active Duty. Mil Med. 2020;185(9-10):e1843-e1846.10.1093/milmed/usaa01232373933 Search in Google Scholar

46. O’Neal KS, Johnson JL, Panak RL. Recognizing and Appropriately Treating Latent Autoimmune Diabetes in Adults. Diabetes Spectr. 2016; 29(4):249-252.10.2337/ds15-0047511152827899877 Search in Google Scholar